Search

An important step towards the development of treatments for cognitive impairment in ageing and neurodegenerative diseases is to identify genetic and environmental modifiers of cognitive function and understand the mechanism by which they exert an effect. In Huntington's disease, the most common autosomal dominant dementia, a small number of studies have identified intellectual enrichment, i.e. a cognitively stimulating lifestyle and genetic polymorphisms as potential modifiers of cognitive function. The aim of our study was to further investigate the relationship and interaction between genetic factors and intellectual enrichment on cognitive function and brain atrophy in Huntington's disease. For this purpose, we analysed data from Track-HD, a multi-centre longitudinal study in Huntington's disease gene carriers and focused on the role of intellectual enrichment (estimated at baseline) and the genes FAN1, MSH3, BDNF, COMT and MAPT in predicting cognitive decline and brain atrophy. We found that carrying the 3a allele in the MSH3 gene had a positive effect on global cognitive function and brain atrophy in multiple cortical regions, such that 3a allele carriers had a slower rate of cognitive decline and atrophy compared with non-carriers, in agreement with its role in somatic instability. No other genetic predictor had a significant effect on cognitive function and the effect of MSH3 was independent of intellectual enrichment. Intellectual enrichment also had a positive effect on cognitive function; participants with higher intellectual enrichment, i.e. those who were better educated, had higher verbal intelligence and performed an occupation that was intellectually engaging, had better cognitive function overall, in agreement with previous studies in Huntington's disease and other dementias. We also found that intellectual enrichment interacted with the BDNF gene, such that the positive effect of intellectual enrichment was greater in Met66 allele carriers than non

Halide perovskites are an extremely promising material platform for solar cells and photonic devices. The role of surface carrier recombination-well known to detrimentally affect the performance of devices-is still not well understood for thin samples where the thickness is comparable to or less than the carrier diffusion length. Here, using time-resolved microspectroscopy along with modeling, we investigate charge-carrier recombination dynamics in halide perovskite CH3NH3PbI3 nanoplatelets with thicknesses from ∼20 to 200 nm, ranging from much lesser than to comparable to the carrier diffusion length. We show that surface recombination plays a stronger role in thin perovskite nanoplatelets, significantly decreasing photoluminescence (PL) efficiency, PL decay lifetime, and photostability. Interestingly, we find that both thick and thin nanoplatelets exhibit a similar increase in PL efficiency with increasing excitation fluence, well described by our excitation saturation model. We also find that the excited carrier distribution along the depth impacts the surface recombination. Using the diffusion-surface recombination model, we determine the surface recombination velocity. This work provides a comprehensive understanding of the role of surface recombination and charge-carrier dynamics in thin perovskite platelets and reveals valuable insights useful for applications in photovoltaics and photonics.

Halide perovskites are an extremely promising material platform for solar cells and photonic devices. The role of surface carrier recombination-well known to detrimentally affect the performance of devices-is still not well understood for thin samples where the thickness is comparable to or less than the carrier diffusion length. Here, using time-resolved microspectroscopy along with modeling, we investigate charge-carrier recombination dynamics in halide perovskite CH3NH3PbI3 nanoplatelets with thicknesses from ∼20 to 200 nm, ranging from much lesser than to comparable to the carrier diffusion length. We show that surface recombination plays a stronger role in thin perovskite nanoplatelets, significantly decreasing photoluminescence (PL) efficiency, PL decay lifetime, and photostability. Interestingly, we find that both thick and thin nanoplatelets exhibit a similar increase in PL efficiency with increasing excitation fluence, well described by our excitation saturation model. We also find that the excited carrier distribution along the depth impacts the surface recombination. Using the diffusion-surface recombination model, we determine the surface recombination velocity. This work provides a comprehensive understanding of the role of surface recombination and charge-carrier dynamics in thin perovskite platelets and reveals valuable insights useful for applications in photovoltaics and photonics.

Primary infection with the human herpesvirus, Epstein-Barr virus (EBV), may result in subclinical seroconversion or may appear as infectious mononucleosis (IM), a lymphoproliferative disease of variable severity. Why primary infection manifests differently between patients is unknown, and, given the difficulties in identifying donors undergoing silent seroconversion, little information has been reported. However, a longstanding assumption has been held that IM represents an exaggerated form of the virologic and immunologic events of asymptomatic infection. T-cell receptor (TCR) repertoires of a unique cohort of subclinically infected patients undergoing silent infection were studied, and the results highlight a fundamental difference between the 2 forms of infection. In contrast to the massive T-cell expansions mobilized during the acute symptomatic phase of IM, asymptomatic donors largely maintain homeostatic T-cell control and peripheral blood repertoire diversity. This disparity cannot simply be linked to severity or spread of the infection because high levels of EBV DNA were found in the blood from both types of acute infection. The results suggest that large expansions of T cells within the blood during IM may not always be associated with the control of primary EBV infection and that they may represent an overreaction that exacerbates disease.

Cytotoxic T cells (CTL) represent the major defense mechanism against the spread of virus infection. It is believed that the pore-forming protein, perforin, facilitates the entry of a series of serine proteases (particularly granzyme B) into the target cell which ultimately leads to DNA fragmentation and apoptosis. We demonstrate here that during CTL-mediated cytolysis the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), an enzyme implicated in the repair of double strand breaks in DNA, is specifically cleaved by an interleukin (IL)-1 beta-converting enzyme (ICE)-like protease. A serine protease inhibitor, 3,4-dichloroisocoumarin (DCl), which is known to block granzyme B activity, inhibited CTL-induced apoptosis and prevented the degradation of DNA-PKcs in cells but failed to prevent the degradation of purified DNA-PKcs by CTL extracts. However, Tyr-Val-Ala-Asp-CH2Cl (YVAD-CMK) and other cysteine protease inhibitors prevented the degradation of purified DNA-PKcs by CTL extracts. Furthermore, incubation of DNA-PKcs with granzyme B did not produce the same cleavage pattern observed in cells undergoing apoptosis and when this substrate was incubated with either CTL extracts or the ICE-like protease, CPP32. Sequence analysis revealed that the cleavage site in DNA-PKcs during CTL killing was the same as that when this substrate was exposed to CPP32. This study demonstrates for the first time that the cleavage of DNA-PKcs in this intact cell system is exclusively due to an ICE-like protease.